Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Incidence of Hyponatremia in PEG-SD Compared to PEG-ELS

This study has been completed.
Salix Pharmaceuticals
Information provided by (Responsible Party):
Thomas Jefferson University Identifier:
First received: July 12, 2010
Last updated: June 4, 2013
Last verified: June 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2012
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
No publications provided by Thomas Jefferson University

Publications automatically indexed to this study by Identifier (NCT Number):